Transcatheter prosthetics in post-radiation aortic stenosis: a review of literature
https://doi.org/10.17650/2782-3202-2023-3-4-35-40
Abstract
Aortic stenosis belongs to the most common acquired cardiac defects in adults, affecting about 2 % of those over 65 years old and 4 % of those over 85 years old. One of the common causes of aortic stenosis is radiation therapy of the mediastinum for malignant neoplasms localised in the thorax. According to the American Society of Clinical Oncology, 10–30 % of patients receiving radiation therapy tend to develop cardiovascular complications, usually after an average follow-up period of 5 to 10 years. About 80 % of cardiovascular complications of radiation therapy are valve diseases, aortic stenosis accounting for a significant part of them. Radiation causes late cicatrisation, fibrous thickening, retraction and calcification of aortic valve cusps, contributing to the restriction of their movement and therefore to the narrowing of the aortic valve orifice.
Patients with aortic valve stenosis have an average lifespan of about 3 years after coronary symptoms or syncopal conditions appear, and about 1.5 years after congestive heart failure begins to manifest. Aortic valve prosthetics is the sole effective and radical treatment method for patients with aortic valve stenosis that allows to improve their condition and prolong their life. Transcatheter aortic valve prosthetics are the treatment of choice in this category of patients.
About the Authors
A. A. Akhobekov
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
Russian Federation
Russian Federation
Albert Amalievich Akhobekov
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
P. A. Zeynalova
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Russian Federation
Russian Federation
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
Bld. 2, 8 Trubetskaya St., Moscow 119991
Yu. E. Ryabukhina
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
Russian Federation
Russian Federation
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
D. A. Chekini
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
Russian Federation
Russian Federation
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
References
1. Stewart B.F., Siscovick D., Lind B.K. et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997;29(3):630–4. DOI: 10.1016/s0735-1097(96)00563-3
2. Egorov I.V. Secondary calcification of intracardiac structures. Praktikuyuschiy vrach = Practicing Physician 2010;1:13–20. (In Russ.).
3. Jaworski C., Mariani J.A., Wheeler G., Kaye D.M. Cardiac complications of thoracic irradiation. J Am Coll Cardiol 2013;61(23):2319–28. DOI: 10.1016/j.jacc.2013.01.090
4. Donnellan E., Masri A., Johnston D.R. et al. Long-term outcomes of patients with mediastinal radiation-associated severe aortic stenosis and subsequent surgical aortic valve replacement: a matched cohort study. J Am Heart Assoc 2017;6(5):e005396. DOI: 10.1161/JAHA.116.005396
5. The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology 2018;23(7):103–55. (In Russ.). DOI: 10.15829/1560-4071-2018-7-103-155
6. Ternovoy S.K., Nikonova M.E., Veselova T.N. et al. Mulslice computed tomography in planning of transcatheter aortic valve implantation. Vestnik rentgenologii i radiologii = Journal of Radiology and Nuclear Medicine 2011;4:18–23. (In Russ.).
7. Cribier A., Eltchaninoff H., Bash A. et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106(24):3006–8. DOI: 10.1161/01.cir.0000047200.36165.b8
8. Chiam P.T., Ruiz C.E. Percutaneous transcatheter aortic valve implantation: evolution of the technology. Am Heart J 2009;157(2):229–42. DOI: 10.1016/j.ahj.2008.10.003
9. Kodali S.K., Williams M.R., Smith C.R. et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012;366(18):1686–95. DOI: 10.1056/NEJMoa1200384
10. Mack M.J., Leon M.B., Thourani V.H. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 2019;380(18):1695–705. DOI: 10.1056/NEJMoa1814052
11. Cao C., Ang S.C., Indraratna P. et al. Systematic review and meta-analysis of transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis. Ann Cardiothorac Surg 2013;2(1):10–23. DOI: 10.3978/j.issn.2225-319X.2012.11.09
12. Di Mario., Eitchaninoff H., Moat N. et al. The 2011–12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients. Euro Intervention 2013;8(12):1362–71. DOI: 10.4244/EIJV8I12A209
13. Gilard M., Eltchaninoff H., Iung B. et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012;366(18):1705–15. DOI: 10.1056/NEJMoa1114705
14. Dijos M., Reynaud A., Leroux L. et al. Efficacy and follow-up of transcatheter aortic valve implantation in patients with radiation-induced aortic stenosis. Open Heart 2015;2(1):e000252. DOI: 10.1136/openhrt-2015-000252
15. Donnellan E., Krishnaswamy A., Hutt-Centeno E. et al. Outcomes of patients with mediastinal radiation-associated severe aortic stenosis undergoing transcatheter aortic valve replacement. Circulation 2018;138(16):1752–4. DOI: 10.1161/CIRCULATIONAHA.118.035514
16. Agrawal N., Kattel S., Waheed S. et al. Clinical outcomes after transcatheter aortic valve replacement in cancer survivors treated with ionizing radiation. Cardiooncology 2019;5:8. DOI: 10.1186/s40959-019-0044-7
17. Zhang D., Guo W., Al-Hijji M.A. et al. Outcomes of patients with severe symptomatic aortic valve stenosis after chest radiation: transcatheter versus surgical aortic valve replacement. J Am Heart Assoc 2019;8(10):e012110. DOI: 10.1161/JAHA.119.012110
18. Guedeney P., Collet J.P. TAVR: A dazzling alternative to SAVR for patients with prior mediastinal radiation. JACC Cardiovasc Interv 2020;13(22):2667–9. DOI: 10.1016/j.jcin.2020.09.025
Review
For citations:
Akhobekov A.A., Zeynalova P.A., Ryabukhina Yu.E., Chekini D.A. Transcatheter prosthetics in post-radiation aortic stenosis: a review of literature. MD-Onco. 2023;3(4):35-40. (In Russ.) https://doi.org/10.17650/2782-3202-2023-3-4-35-40
Views:
186
Email this article 